Best Practices, LLC Home
View Cart Search the Site Contact Best Practices, LLC Press Room of Best Practices, LLC
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Sales and Marketing > New Product Development and Launch > Optimizing Product Portfolio > Early Stage Planning

Early Stage Planning Research

Fixed Dose Combination Products: Successful Strategies for Developing and Bringing FDC Products to Market 
Non-members: Click here to review a complimentary excerpt from "Fixed Dose Combination Products: Successful Strategies for Developing and Bringing FDC Products to Market" STUDY OVERVIEW The economic advisability of developing fixed dose combination products can be difficult to determine owing to the many associated development and commercial challenges... (ID 5096)
Companies Profiled: Abbott, Xanodyne Pharmaceuticals, Victory, Valeant, more ...
Price: $4100.00   Free Excerpt Available


Pharmaceutical Early-Stage Commercialization: Using Portfolio Management to Drive Success 
Non-members: Click here to review a complimentary excerpt from "Pharmaceutical Early-Stage Commercialization: Using Portfolio Management to Drive Success" STUDY OVERVIEW The investment decisions that drive product development cycles are exceedingly complex... (ID 5026)
Companies Profiled: Abbott Laboratories, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $1847.00   Free Excerpt Available


Using Cross-Functional Relationships to Optimize Early-Stage Commercialization 
Non-members: Click here to review a complimentary excerpt from "Using Cross-Functional Relationships to Optimize Early-Stage Commercialization" STUDY OVERVIEW Lengthy and expensive product development cycles make it essential for pharmaceutical companies to allocate limited staff and resources to the development of compounds with the greatest potential market value... (ID 5023)
Companies Profiled: Abbott Laboratories, Alexion Pharmaceuticals, Altus Biologics, Amgen, more ...
Price: $2136.00   Free Excerpt Available


Pharmaceutical Early-Stage Commercialization: Structure & Functions That Lead to Success 
Non-members: Click here to review a complimentary excerpt of "Pharmaceutical Early-Stage Commercialization: Structure & Functions that Lead to Success" STUDY OVERVIEW Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value... (ID 5020)
Companies Profiled: Abbott Laboratories, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $2598.00   Free Excerpt Available


Fostering Cross-Functional Portfolio Management 
Study Overview While top-performing pharmaceutical companies recognize that innovative drug discovery depends upon a deep understanding of market needs and the research skill of top scientists working with state-of-the-art technologies, most companies commonly struggle with the decision to commit resources to a product that may or may not make it past the next phase... (ID 4678)
Companies Profiled: Eli Lilly, Pfizer, Amgen, Janssen
Price: $991.95


Market Research for Pharmaceutical Launches 
As the market for pharmaceutical products grows, top-performing pharmaceutical companies must involve marketing as early as possible to achieve worldwide appeal... (ID 4571)
Companies Profiled: Sanofi-aventis, Merck, Eli Lilly, GlaxoSmithKline , more ...
Price: $817.95


Portfolio Development, Management & Measurement 
Leading companies invest considerable staff, time, resources and share of mind in the area of portfolio development, management and measurement... (ID 4317)
Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ...
Price: $1249.95


Managing Processes, Tools and Techniques 
When it comes to managing the tools and processes of early-stage marketers, benchmark partners stress the importance of executing fundamentals: managing processes, managing across functions, working effectively among teams and departments, and conducting effective market research that will yield insights and pathways to commercial success... (ID 4316)
Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ...
Price: $1449.95


Developing "Soft and Hard Skills" to Increase Commercialization Effectiveness 
Soft skills and interpersonal characteristics are often the main differentiation between a successful commercialization employee and one who is less influential... (ID 4315)
Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ...
Price: $516.95


Optimizing Process Integration Through Structure and Resources 
Portfolio management and, especially, commercialization functions are becoming more critical to company bottom-line performance as a result of numerous internal and external factors, including weak drug pipelines and intensive pharmaceutical competition... (ID 4314)
Companies Profiled: Allergan, Abbott, Bayer, Bristol-Myers Squibb, more ...
Price: $1099.95



 


All contents copyright © 1999-2012 Best Practices, LLC 6350 Quadrangle Drive, Chapel Hill, NC 27517 USA (919) 403-0251.
Site Map | Please see our Terms and Conditions of Use and Privacy Policy.

This site is optimized for 4.0 and higher versions of Microsoft Internet Explorer and Netscape Navigator.
If you experience difficulties using our e-commerce system, please check your browser version and our FAQs.